1. Home
  2. SIBN vs FLGT Comparison

SIBN vs FLGT Comparison

Compare SIBN & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

HOLD

Current Price

$17.48

Market Cap

886.9M

Sector

Health Care

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$28.05

Market Cap

867.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIBN
FLGT
Founded
2008
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
886.9M
867.4M
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
SIBN
FLGT
Price
$17.48
$28.05
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$25.57
$28.33
AVG Volume (30 Days)
533.2K
205.0K
Earning Date
02-23-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,578,000.00
$315,549,000.00
Revenue This Year
$21.44
$16.84
Revenue Next Year
$15.37
$9.74
P/E Ratio
N/A
N/A
Revenue Growth
23.27
13.61
52 Week Low
$12.50
$14.57
52 Week High
$21.89
$31.04

Technical Indicators

Market Signals
Indicator
SIBN
FLGT
Relative Strength Index (RSI) 35.31 55.75
Support Level $17.01 $27.56
Resistance Level $21.89 $28.44
Average True Range (ATR) 0.91 0.71
MACD -0.39 0.18
Stochastic Oscillator 8.82 82.51

Price Performance

Historical Comparison
SIBN
FLGT

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: